AstraZeneca scores win as diabetes drug shown to slow kidney disease
(Reuters Health)

AstraZeneca`s diabetes treatment Farxiga has proven to be `overwhelmingly` effective at slowing chronic kidney disease ahead of the scheduled end of a drug trial, the British drugmaker said, potentially opening a new area of treatment outside diabetes.